MHK
25
5
MPC
28
3
MKC
54
3
UA
48
6
MDT
59
4
LB
16
9
HBAN
47
7
ACN
54
2
CCI
30
2
FITB
36
3
SLG
37
6
VNO
46
6
ROP
44
6
AIV
39
6
MMC
46
5
LMT
29
-5
ROK
46
3
UAL
73
3
LH
33
3
CSCO
63
5
MHK
25
5
MPC
28
3
MKC
54
3
UA
48
6
MDT
59
4
LB
16
9
HBAN
47
7
ACN
54
2
CCI
30
2
FITB
36
3
SLG
37
6
VNO
46
6
ROP
44
6
AIV
39
6
MMC
46
5
LMT
29
-5
ROK
46
3
UAL
73
3
LH
33
3
CSCO
63
5
Financhill
Back

X4 Pharmaceuticals 10K Form

Sell
47

XFOR
X4 Pharmaceuticals

Last Price:
$0.60
Seasonality Move:
19.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive XFOR News And Ratings

See the #1 stock for the next 7 days that we like better than XFOR

XFOR Financial Statistics

Sales & Book Value

Annual Sales: $3M
Cash Flow: $-34.1M
Price / Cash Flow: 0
Annual Sales: $0.35
Price / Book: 1.75

Profitability

EPS (TTM): -0.08000
Net Income (TTM): $-16.8M
Gross Margin: --
Return on Equity: -30.6%
Return on Assets: -10.2%

X4 Pharmaceuticals Earnings Forecast

Key X4 Pharmaceuticals Financial Ratios

  • The Interest Expense is -5.71% of Operating Income.
  • Per Share Earnings over the last 9 years have been positive in 5 years.

X4 Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: XFOR
CUSIP: 98420X
Website: x4pharma.com

Debt

Debt-to-Equity Ratio: 1.26
Current Ratio: 4.89
Quick Ratio: 4.65

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

XFOR Technical Analysis vs Fundamental Analysis

Sell
47
X4 Pharmaceuticals (XFOR) is a Sell

Is X4 Pharmaceuticals a Buy or a Sell?